HomeCompareHOLX vs FANG

HOLX vs FANG: Dividend Comparison 2026

HOLX yields 2.65% · FANG yields 2.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FANG wins by $69.67M in total portfolio value
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
FANG
FANG
● Live price
2.04%
Share price
$198.65
Annual div
$4.05
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$69.70M
Annual income
$63,694,114.45
Full FANG calculator →

Portfolio growth — HOLX vs FANG

📍 FANG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXFANG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + FANG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
FANG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
FANG
Annual income on $10K today (after 15% tax)
$173.29/yr
After 10yr DRIP, annual income (after tax)
$54,139,997.28/yr
At 15% tax rate, FANG beats the other by $54,139,730.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + FANG for your $10,000?

HOLX: 50%FANG: 50%
100% FANG50/50100% HOLX
Portfolio after 10yr
$34.86M
Annual income
$31,847,214.24/yr
Blended yield
91.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FANG right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
FANG
Analyst Ratings
1
Strong
45
Buy
5
Hold
Consensus: Buy
Price Target
$182.64
-8.1% upside vs current
Range: $100.00 — $240.00
Altman Z
1.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
FANG buys
0
No recent congressional trades found for HOLX or FANG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXFANG
Forward yield2.65%2.04%
Annual dividend / share$2.00$4.05
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%100%
Portfolio after 10y$23.6K$69.70M
Annual income after 10y$314.03$63,694,114.45
Total dividends collected$2.9K$69.21M
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldBuy
Analyst price target$77.80$182.64

Year-by-year: HOLX vs FANG ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrFANG PortfolioFANG Income/yrGap
1← crossover$10,965$264.73$11,108$407.75$143.00FANG
2$12,004$271.27$12,732$846.58$728.00FANG
3$13,121$277.55$15,437$1,813.77$2.3KFANG
4$14,323$283.54$20,628$4,110.50$6.3KFANG
5$15,615$289.27$32,339$10,266.86$16.7KFANG
6$17,003$294.73$64,688$30,085.07$47.7KFANG
7$18,493$299.93$181,701$112,484.96$163.2KFANG
8$20,093$304.87$784,997$590,576.84$764.9KFANG
9$21,809$309.57$5,609,019$4,769,072.49$5.59MFANG
10$23,649$314.03$69,695,765$63,694,114.45$69.67MFANG

HOLX vs FANG: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

FANGEnergy

Diamondback Energy, Inc., an independent oil and natural gas company, focuses on the acquisition, development, exploration, and exploitation of unconventional and onshore oil and natural gas reserves in the Permian Basin in West Texas. It focuses on the development of the Spraberry and Wolfcamp formations of the Midland basin; and the Wolfcamp and Bone Spring formations of the Delaware basin, which are part of the Permian Basin in West Texas and New Mexico. As of December 31, 2021, the company's total acreage position was approximately 524,700 gross acres in the Permian Basin; and estimated proved oil and natural gas reserves were 1,788,991 thousand barrels of crude oil equivalent. It also held working interests in 5,289 gross producing wells, as well as royalty interests in 6,455 additional wells. In addition, the company owns mineral interests approximately 930,871 gross acres and 27,027 net royalty acres in the Permian Basin and Eagle Ford Shale; and owns, operates, develops, and acquires midstream infrastructure assets, including 866 miles of crude oil gathering pipelines, natural gas gathering pipelines, and an integrated water system in the Midland and Delaware Basins of the Permian Basin. Diamondback Energy, Inc. was founded in 2007 and is headquartered in Midland, Texas.

Full FANG Calculator →
📬

Get this HOLX vs FANG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.